UCSF CME: 39th Annual Advances In Heart Disease 2022 (Videos)

Our 39th annual course will again strive to present topics that highlight new evidence-based medicine findings reported within the last one to two years that impact clinical practice. These will range across a variety of cardiologic subspecialty interests including heart failure, arrhythmias, cardiac surgery, gene therapy, aortic diseases, prevention and artificial intelligence.
Our faculty will include a distinguished group of visiting academicians from North America together with outstanding teachers and clinicians from the University of California, San Francisco.
All sessions will be recorded and made available to participants for online viewing 30 days post course.
TARGET AUDIENCE
This course is intended for cardiovascular specialists, practicing cardiologists, internists, family physicians, cardiovascular
Objectives:

Providing the best management of coronary heart disease, hypertension, lipid disorders, diabetes, systolic and diastolic heart failure, atrial fibrillation and flutter, STEMI and non-STEMI, thromboembolic disease
Refining considerations for atrial fibrillation, atrial flutter, and ventricular tachycardia ablation
Applying the best considerations of surgical revascularization or percutaneous intervention for management of coronary heart disease
Recognizing risk stratification of cardiovascular disease
Optimizing the management of ascending thoracic aorta disease
Optimizing the management of pulmonary embolism
Recognizing the role of cardiac surgery in the management of endocarditis
Recognizing the genetic basis of cardiovascular diseases
Recognizing the importance of deep empathy in patient interactions
Recognizing that pathophysiology of diseases and treatment options differ among racial and ethnic groups
Optimizing the management of cardiac amyloidosis
Recognizing the connection between the mind and the heart
Recognizing the role of air pollution as a risk factor for cardiovascular diseases

Course Outline:

Friday, December 2, 2022

7:00 a.m.
Registration and Continental Breakfast

8:10 a.m.
Welcome and Symposium Overview
Peter Ganz, MD

Session: Frontiers in Cardiology: Genetics, Artificial Intelligence and Deep Empathy
Chair: Priscilla Hsue, MD

8:15 a.m.
The Mind-Heart Connection: Stress and Trauma as Cardiovascular Risk Factors
Ahmed Tawakol, MD

8:55 a.m.
Artificial Intelligence in Cardiology
Geoff Tison, MD, MPH

9:35 a.m.
Ascending Thoracic Aortic Aneurysms: Evaluation, Management and Genetic Testing
Lisa Wilsbacher, MD, PhD

10:15 a.m.
Coffee Break

10:30 a.m.
Update on Transthyretin Amyloidosis
Mandar Aras, MD, PhD

11:10 a.m.
Gene Targeting for Cardiometabolic Diseases – Where are We?
John Chorba, MD

11:50 a.m.
Elliot Rapaport Keynote Lecture: High Performance with Deep Empathy Medicine
Eric Topol, MD

12:40 a.m.
Lunch (on Your Own)

Session: State-of-the-Art: Cardiovascular Interventions
Chair: Lucas Zier, MD, MS

2:00 p.m.
New Approaches to Pulmonary Embolism
Gregory Piazza, MD, MS

2:40 p.m.
Physiological Assessment of Coronary Stenosis Severity by CT Angiography and in the Cath Lab
William Fearon, MD

3:20 p.m.
Expanding Options in the Management of Endocarditis
Amy Fiedler, MD, MS

Ann Bolger, MD

4:00 p.m.
Coffee Break

4:15 p.m.
Surgical Approaches to Advanced Heart Failure
Jason Smith, MD

4:55 p.m.
Revascularization in Stable Coronary Disease: Sorting through the Evidence
Jeffrey Zimmet, MD, PhD

5:35 p.m.
Adjourn

Saturday, December 3, 2022

7:30 a.m.
Continental Breakfast

8:05 a.m.
Announcements
Peter Ganz, MD

Session: Advances and Controversies in Electrophysiology
Chair: Nora Goldschlager, MD

8:10 a.m.
Defining Sudden Cardiac Death in 2022
Zian Tseng, MD, MAS

8:50 a.m.
ECG Findings Suggesting High Arrhythmic Risk
Melvin Scheinman, MD

9:30 a.m.
Debate: AFib Ablation Should be First Line Therapy in Patients with Symptomatic AFib
Adam Lee, MD

Tommy Dewland, MD

10:10 a.m.
Coffee Break

10:25 a.m.
Advances in Cardiac Imaging for Arrhythmia Etiology, Prognosis and Therapy
Edward Gerstenfeld, MD, MS

11:05 a.m.
The Effect of Alcohol, Exercise and Lifestyle on Atrial Fibrillation
Gregory Marcus, MD, MAS

11:45 a.m.
Interventions for Novel/Genetic Arrhythmias
Vasanth Vedantham, MD, PhD

12:25 p.m
Debate: Prophylactic Primary Prevention ICD in Dilated Cardiomyopathy with Heart Failure
Byron Lee, MD, MS

Joshua Moss, MD, MS

1:05 p.m.
Lunch (on your own)

Session: Managing Heart Failure
Chair: Jonathan Davis, MD, MPHS

2:20 p.m.
Cardiogenic Shock
Jaya Mallidi, MD

3:00 p.m.
New Heart Failure Guidelines for HFrEF
Jonathan Davis, MD, MPHS

3:40 p.m.
New Heart Failure Guidelines for HFpEF
Jonathan Davis, MD, MPHS

4:20 p.m.
Coffee Break

4:35 p.m.
Polypharmacy and Medication Costs for Guideline Directed Medical Therapy for HFrEF
Anusha McNamara, PharmD

Rose Pavlakos, PharmD

5:15 p.m.
Remote Monitoring of Patients with
Liviu Klein, MD, MS

Cardiovascular Diseases

5:55 p.m.
Adjourn

Sunday, December 4, 2022

7:30 a.m.
Continental Breakfast

8:00 a.m.
Announcements
Peter Ganz, MD

Session: Managing Cardiovascular Risk
Chair: Binh An P. Phan, MD

8:05 a.m.
The Effect of Salt and Salt Substitutes Consumption on Clinical Outcomes in Hypertension and Heart Failure
Michael Crawford, MD

8:45 a.m.
Managing Cardiovascular Risk in the Elderly
Carlin Long, MD

9:25 a.m.
Current Cholesterol Guidelines: Controversies and Agreements
Peter Ganz, MD

10:05 a.m.
Where Are We with Non-Statin Lipid Modifying Therapy?
Jorge Plutzky, MD

10:45 a.m.
Management of Cardiovascular Risk and Chronic Kidney Disease Progression with Patients with Diabetes
Lisa Murphy, MD, PhD

11:25 a.m.
Impact of Air Pollution on Cardiovascular
Karol Watson, MD, PhD

Outcomes

12:05 p.m.
Adjourn